Colgate-Palmolive (CL) Stock Forecast & Price Target

$92.19 -0.14 (-0.15%)

As of 03:59 PM Eastern

Colgate-Palmolive - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Hold

Based on 21 Analyst Ratings

Sell
1

Hold
9

Buy
11

Based on 21 Wall Street analysts who have issued ratings for Colgate-Palmolive in the last 12 months, the stock has a consensus rating of "Hold." Out of the 21 analysts, 1 has given a sell rating, 9 have given a hold rating, and 11 have given a buy rating for CL.

Consensus Price Target

$102.39
11.06% Upside

According to the 21 analysts' twelve-month price targets for Colgate-Palmolive, the average price target is $102.39. The highest price target for CL is $110.00, while the lowest price target for CL is $86.00. The average price target represents a forecasted upside of 11.06% from the current price of $92.19.

Get the Latest News and Ratings for CL and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Colgate-Palmolive and its competitors.

CL Analyst Ratings Over Time

Type	Current Forecast 4/30/24 to 4/30/25	1 Month Ago 3/31/24 to 3/31/25	3 Months Ago 1/31/24 to 1/30/25	1 Year Ago 5/1/23 to 4/30/24
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	11 Buy rating(s)	11 Buy rating(s)	11 Buy rating(s)	12 Buy rating(s)
Hold	9 Hold rating(s)	9 Hold rating(s)	9 Hold rating(s)	3 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$102.39	$101.78	$102.00	$91.44
Forecasted Upside	11.06% Upside	8.46% Upside	12.14% Upside	-0.50% Downside
Consensus Rating	Hold	Hold	Hold	Moderate Buy

CL Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

CL Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Colgate-Palmolive Stock vs. The Competition

Type	Colgate-Palmolive	Consumer Staples Companies	S&P 500
Consensus Rating Score	2.48	2.55	2.54
Consensus Rating	Hold	Moderate Buy	Moderate Buy
Predicted Upside	11.06% Upside	54.62% Upside	19.72% Upside
News Sentiment Rating	Positive News See Recent CL News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
4/28/2025	Citigroup 2 of 5 stars	Filippo Falorni Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Buy ➝ Buy	$103.00 ➝ $108.00	+18.78%
4/28/2025	JPMorgan Chase & Co. 2 of 5 stars	Andrea Teixeira Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Overweight ➝ Overweight	$95.00 ➝ $103.00	+12.05%
4/17/2025	UBS Group 3 of 5 stars	Peter Grom Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Buy ➝ Buy	$105.00 ➝ $109.00	+14.69%
4/11/2025	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lauren Lieberman Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Equal Weight ➝ Equal Weight	$89.00 ➝ $86.00	-8.50%
4/2/2025	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Chris Carey Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Underweight ➝ Underweight	$83.00 ➝ $88.00	-5.90%
3/31/2025	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Korinne Wolfmeyer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Overweight ➝ Overweight	$108.00 ➝ $107.00	+15.39%
2/3/2025	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mark Astrachan Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Hold ➝ Hold	$95.00 ➝ $93.00	+7.86%
2/3/2025	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	Olivia Tong Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$110.00 ➝ $105.00	+21.20%
2/3/2025	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Dara Mohsenian Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Overweight ➝ Overweight	$111.00 ➝ $104.00	+20.04%
1/29/2025	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Nik Modi Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Sector Perform ➝ Sector Perform	$101.00 ➝ $101.00	+12.10%
Get the Latest News and Ratings for CL and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Colgate-Palmolive and its competitors with MarketBeat's FREE daily newsletter.
1/8/2025	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Moskow Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Buy ➝ Buy	$110.00 ➝ $100.00	+14.53%
9/9/2024	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Hold	$107.00 ➝ $109.00	+1.06%
8/1/2024	Redburn Atlantic Subscribe to MarketBeat All Access for the recommendation accuracy rating	E. Lewis Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold
7/30/2024	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Market Perform ➝ Market Perform	$100.00 ➝ $103.00	+3.00%
7/26/2024	Hsbc Global Res Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Zamacona Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
7/26/2024	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Hold
7/24/2024	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Hold	$103.00 ➝ $95.00	-1.61%
7/18/2024	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$100.00 ➝ $106.00	+6.91%
7/10/2024	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$100.00 ➝ $110.00	+13.26%
6/24/2024	BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating	K. Grundy Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform	$109.00	+12.06%
5/15/2024	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating	C. Graja Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Buy ➝ Buy	$97.00 ➝ $107.00	+13.01%
3/1/2024	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$93.00	+7.50%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 12:01 AM ET.

Should I Buy Colgate-Palmolive Stock? CL Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, April 23, 2025. Please send any questions or comments about these Colgate-Palmolive pros and cons to contact@marketbeat.com.

Colgate-Palmolive
Bull Case

Here are some ways that investors could benefit from investing in Colgate-Palmolive:

Colgate-Palmolive recently reported earnings per share (EPS) of $0.91, surpassing analysts' expectations, indicating strong financial performance.
The company has initiated a significant share buyback program, allowing for the repurchase of up to $5 billion in shares, which often signals management's belief that the stock is undervalued.
Colgate-Palmolive has increased its quarterly dividend to $0.52, reflecting a commitment to returning value to shareholders, with a current annualized dividend yield of approximately 2.20%.
The current stock price is around $95.76, which is near its twelve-month high, suggesting positive market sentiment and potential for further growth.
With a return on equity of 477.77%, Colgate-Palmolive demonstrates effective management of shareholder equity, which can be attractive to investors looking for strong financial metrics.

Colgate-Palmolive
Bear Case

Investors should be bearish about investing in Colgate-Palmolive for these reasons:

Despite recent positive earnings, the stock has seen price target reductions from several analysts, indicating potential concerns about future performance.
Colgate-Palmolive's market capitalization is substantial at $77.67 billion, which may limit growth potential compared to smaller, more agile companies.
The company's price-to-earnings (P/E) ratio of 27.20 suggests that the stock may be overvalued relative to its earnings, which could deter value-focused investors.
Analysts have mixed ratings on the stock, with a significant number assigning hold ratings, which may indicate uncertainty about its future trajectory.
Colgate-Palmolive operates in a competitive market, and any shifts in consumer preferences or economic conditions could adversely affect its sales and profitability.

CL Forecast - Frequently Asked Questions

: According to the research reports of 21 Wall Street equities research analysts, the average twelve-month stock price forecast for Colgate-Palmolive is $102.39, with a high forecast of $110.00 and a low forecast of $86.00.
: 21 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Colgate-Palmolive in the last year. There is currently 1 sell rating, 9 hold ratings and 11 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CL shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CL, but not buy additional shares or sell existing shares.
: According to analysts, Colgate-Palmolive's stock has a predicted upside of 11.06% based on their 12-month stock forecasts.
: Colgate-Palmolive has been rated by research analysts at Barclays, Citigroup, JPMorgan Chase & Co., Morgan Stanley, Piper Sandler, Raymond James, Stifel Nicolaus, UBS Group, and Wells Fargo & Company in the past 90 days.
: Analysts like Colgate-Palmolive less than other "consumer staples" companies. The consensus rating for Colgate-Palmolive is Hold while the average consensus rating for "consumer staples" companies is Moderate Buy. Learn more on how CL compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top-Rated Stocks

More Ratings Tools

This page (NYSE:CL) was last updated on 4/30/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Colgate-Palmolive (CL) Stock Forecast & Price Target